Globalisation and Its Impact on Competitiveness: the Case of the British and German Pharmaceutical Industry

Christel Lane and Jocelyn Probert

Working Papers from Centre for Business Research, University of Cambridge

Abstract: This paper assesses the degree of financial and economic globalisation of British and German pharmaceutical companies during 1990 and 2001 and explores the changing balance between globalisation and national embeddedness. It tries to explain both the much lower degree of globalisation of German as compared to British companies in 1990, as well as their catching up at the beginning of the 21st century. The paper suggests that the lesser degree of globalisation of German firms during most of the 1990s partly explains their slide in competitiveness during this period. The conclusion examines prospects for the future of firms in both economies. The paper draws on detailed industry data, as well as case studies of the major firms in the two national industries.

Keywords: globalisation; pharmaceutical industry; performance; British-German comparison (search for similar items in EconPapers)
JEL-codes: L22 L65 P12 (search for similar items in EconPapers)
Date: 2003-06
New Economics Papers: this item is included in nep-eec
Note: PRO-1
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.jbs.cam.ac.uk/wp-content/uploads/2023/05/cbrwp262.pdf (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:cbr:cbrwps:wp262

Access Statistics for this paper

More papers in Working Papers from Centre for Business Research, University of Cambridge
Bibliographic data for series maintained by Ruth Newman ().